Skip to main content
Clinical Trials/NCT05009524
NCT05009524
Unknown
N/A

The Interactive Physical and Cognitive Exercise System (iPACES v3) to Benefit Brain Health in Mild Cognitive Impairment (MCI): A Randomized Clinical Trial of Neuro-exergaming Pedal-to-play (iPACES) vs Pedal-while-play (PACE)

iPACES LLC1 site in 1 country120 target enrollmentAugust 23, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
MCI
Sponsor
iPACES LLC
Enrollment
120
Locations
1
Primary Endpoint
executive function
Last Updated
4 years ago

Overview

Brief Summary

The primary purpose of this study is to attempt to replicate and extend promising pilot findings regarding the cognitive benefits of in-home neuro-exergaming with iPACES (interactive Physical and Cognitive Exercise System v3) for persons with mild cognitive impairment (MCI). Participants will include persons with MCI and their co-residing partner who both exercise at home 3-5 times per week for at least 6 months and are followed through one year. All participation is "remote" (completed at home), with all equipment (pedaler, tablet, etc.) supplied directly to the home, and with all study measures completed via videoconference and mail.

Detailed Description

A specific aim is to evaluate the potentially unique contribution of combining mental and physical exercise in an interactive way: "pedal-to-play" (iPACES), as compared with non-interactive, but simultaneous: "pedal-while-play" (PACE).

Registry
clinicaltrials.gov
Start Date
August 23, 2021
End Date
August 31, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
iPACES LLC
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 50 years of age or older
  • co-residing study partner (spouse, adult child, roommate in same home) willing to participate in the study as an exercising participant as well
  • self or partner meets criteria for MCI (per site staff/MD/neuropsychologist and confirmed by study-administered Montreal Cognitive Assessment; MoCA; score = between 16-26, non-inclusive; Milani, 2018)
  • available for participation for one year (tablet surveys, videoconference evaluations)
  • willing and able to exercise 3-5 times per week for at least 6 months
  • can pedal an under-table elliptical
  • can read off of a small tablet screen
  • proficient in English (speaking and reading for completion of interview, surveys, game)
  • can participate in testing and read and operate tablet touch screen (adequate hearing, vision, speech)
  • written approval from primary care physician and cardiologist (if applicable) to participate in exercise for this study

Exclusion Criteria

  • already exercising at recommended levels (45 min of moderate intensity aerobic exercise 5-7x/wk)
  • significant history of cardiovascular problems
  • significant history of stroke
  • significant history of memory problems (e.g., dementia/Alzheimer's)
  • significant history of other neurological condition (e.g., seizures, Parkinson's, etc.)
  • tremor (idiopathic) such that would interfere with touch-screen use required throughout the study (surveys, game-play, etc.)
  • not prone to cybersickness (e.g., "car sickness" or problems with "screen time")
  • cannot provide informed consent (i.e., when phone screened with the Impaired Decision Making Capacity screen)

Outcomes

Primary Outcomes

executive function

Time Frame: change from baseline to 6 months

cognitive function composite score from neuropsychological tests (e.g., Stroop)

everyday function

Time Frame: change from baseline to 6 months

subjective cognitive function in everyday living (e.g., Ecological Validity Scale)

Secondary Outcomes

  • biomarker(change from baseline to 6 months)

Study Sites (1)

Loading locations...

Similar Trials